<DOC>
	<DOCNO>NCT01962909</DOCNO>
	<brief_summary>The purpose clinical trial study experimental drug call PTP-01 use image agent diagnosis pancreatic cancer . Currently , pancreatic cancer diagnose use CT MRI scan miss small pancreatic cancer , particularly early stage disease . Researchers University Virginia identify biomarker pancreatic cancer call plectin , specific pancreatic cancer , non-cancerous condition involve pancreas . These researcher also develop PTP-01 , experimental drug may use SPECT image detect pancreatic cancer cell human .</brief_summary>
	<brief_title>Phase 0 Biodistribution Novel Imaging Resectable Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>subject undergoing resection pancreas pancreatic ductal adenocarcinoma ( PDAC ) subject must adequate renal function ECOG performance status 02 woman childbearing age men must agree use contraception prior study subject receive investigational agent significant history uncontrolled cardiac disease central nervous system ( CNS ) disease pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Pancreatic Resection</keyword>
</DOC>